Development and validation of an interpretable deep learning framework for Alzheimer’s disease classification
Shangran Qiu(Boston University), Vijaya B. Kolachalama(Boston University), E. Alton Sartor(Boston University), Rhoda Au(Boston University), Prajakta Joshi(Boston University), Michelle Kaku(Icahn School of Medicine at Mount Sinai), Gary H. Chang(Boston University), Yazan J. Alderazi(Texas Tech University), Marie Saint‐Hilaire(Boston University), Jing Yuan(Shandong Provincial QianFoShan Hospital), Sanford Auerbach(Boston University), Cody Karjadi(Boston University), Sachin Kedar(University of Nebraska Medical Center), Arun Swaminathan(University of Pittsburgh), Shuhan Zhu(Boston University), Brigid Dwyer(Boston University), Chonghua Xue(Boston University), Yan Zhou(University of Electronic Science and Technology of China), Anant S. Joshi(Georgia Institute of Technology), Xiao Zhou(Collaborative Innovation Center of Chemical Science and Engineering Tianjin), Matthew I. Miller(Boston University)
Cited by 487
Related Papers
Clinical Pharmacokinetics of Tacrolimus
|Clinical Pharmacokinetics|1995|802
Cumulative Head Impact Exposure Predicts Later-Life Depression, Apathy, Executive Dysfunction, and Cognitive Impairment in Former High School and College Football Players
|Journal of Neurotrauma|2016|565
Multimodal deep learning for Alzheimer’s disease dementia assessment
|Nature Communications|2022|390
Inosine to Increase Serum and Cerebrospinal Fluid Urate in Parkinson Disease
|JAMA Neurology|2014|239